PRIMARY HEALTH PROPERTIES PLC - PDMR dealing

PDMR dealing

Primary Health Properties PLC
(Incorporated in the United Kingdom)
Company Number: 3033634
LSE Share Code: PHP
JSE Share Code: PHP
ISIN Code: GB00BYRJ5J14
LEI: 213800Y5CJHXOATK7X11
("PHP" or the "Company")


PDMR dealing

On 8 May 2024, the Remuneration Committee of Primary Health Properties PLC (the "Company" or
"PHP") made the following award of nil-cost options under the Company's 2021 Long-term Incentive
Plan ("LTIP") to a Person Discharging Managerial Responsibilities ("PDMR"):

 PDMR                            Number of shares under option

 Mark Davies                     886,824



The number of nil-cost options was calculated by reference to a price of £0.9472, being the average of
the closing middle market quotations for the Company's ordinary shares on 7 May 2024, 3 May 2024
and 2 May 2024.

The nil-cost options will normally vest on the third anniversary of grant, subject to the attainment of
performance conditions. The Remuneration Committee has the discretion to adjust the awards
downwards at vesting for malus reasons. Details of the operation of the LTIP are set out in the
Company's 2023 Report and Accounts.

Details of the transaction referenced above are included below in accordance with Article 19 of the
retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

 1             Details of Person Discharging Managerial Responsibility/person closely
               associated with them ("PCA")
 (a)           Name                               Mark Davies

 2             Reason for the notification

 (a)           Position/status                               Chief Executive Officer

 (b)           Initial notification/ amendment               Initial notification

 3             Details of the issuer, emission allowance market participant, auction platform,
               auctioneer or auction monitor

 (a)           Name                                          Primary Health Properties PLC

 (b)           LEI                                           213800Y5CJHXOATK7X11

 4             Details of the transaction(s): section to be repeated for (i) each type of instrument;
               (ii) each type of transaction; (iii) each date: and (iv) each place where transactions
               have been conducted
 (a)           Description of the financial instrument          Ordinary shares of 12.5p
                                                                ISIN: GB00BYRJ5J14

 (b)           Nature of the transaction                     Award of nil-cost options over the
                                                             Company's ordinary shares

 (c)           Price(s) and volume(s)                        Price(s)                  Volume(s)
                                                         Nil cost                  886,824


 (d)         Aggregated volume price                     Single transaction: N/A

 (e)         Date of transaction                         8 May 2024

 (f)         Place of transaction                        n/a



More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk



Further details:

 Richard Howell                                                Toby Newman
 Chief Financial Officer                                       Company Secretary & Chief Legal
 Tel: +44 (0) 776 6072 272                                     Officer
                                                               Tel: +44 (0) 772 9047 959
 David Rydell / Stephanie           Whitmore   (Buchanan
 Communications)
 Tel: +44 (0) 20 7466 5066


The Company has a primary listing on the London Stock Exchange and a secondary listing on the
JSE Limited.



United Kingdom
9 May 2024

Sponsor: PSG Capital

Date: 09-05-2024 03:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.